Lexington Biosciences Inc. (LXGTF)

[StockBro75]

The "self-measurement" part of LXGTF is a big deal:

The unit is designed to communicate via Bluetooth technology to provide up-to-date and accurate readings of an individual’s complete cardiovascular health through electronic monitoring for cardiovascular risk-assessment and to aid treatment effectiveness for the prevention of heart attack and stroke.

HeartSentry targets the rapidly growing self-measurement medical device sector and is deigned for both personal and clinical use. Simplicity and functionality are key elements of the design.

Lexington BioSciences are developers of clinical grade cardiovascular self measurement solutions and HeartSentry is it’s flagship, and first device currently advancing to commercial deployment.